Status:

COMPLETED

Clinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast Cancer

Lead Sponsor:

Sysmex America, Inc.

Conditions:

Breast Neoplasms

Breast Diseases

Eligibility:

All Genders

18+ years

Brief Summary

The study will determine the sensitivity, specificity, negative predictive value and positive predictive value of the OSNA Breast Cancer System by comparing its performance to permanent section Hemato...

Eligibility Criteria

Inclusion

  • Male or Female patients, over the age of 18, diagnosed pre-surgically with T1 or T2 breast cancer and scheduled for surgery including sentinel node dissection.
  • Patients who have read and understand the informed consent form and are capable and willing to provide written informed consent.

Exclusion

  • Patients diagnosed pre-surgically with large or locally advanced (T3 and T4) breast cancers.
  • Patients diagnosed with inflammatory breast cancer.
  • Patients diagnosed with ductal carcinoma in situ (DCIS) when breast conserving is to be done.
  • Patients who are pregnant, as confirmed by a patient/treating physician interview.
  • Patients with suspicious palpable axillary lymph nodes.
  • Patients currently being treated for or previously diagnosed with, another type of carcinoma.
  • Patients who have undergone prior non-oncologic breast surgery or axillary surgery.
  • Patients who have received pre-operative systemic therapy.
  • Patients who are incapable of providing written informed consent.
  • Patients who have been judged to be inappropriate by a medical care provider (i.e. surgeon, oncologist, pathologists, etc.).

Key Trial Info

Start Date :

February 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

496 Patients enrolled

Trial Details

Trial ID

NCT01136369

Start Date

February 1 2007

End Date

December 1 2008

Last Update

June 3 2010

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

John Wayne Cancer Institute

Santa Monica, California, United States, 90404

2

WellStar Health Systems

Marietta, Georgia, United States, 30062

3

Washington University Medical School

St Louis, Missouri, United States, 63110

4

Beth Israel Medical Center

New York, New York, United States, 10003